HONOLULU, Oct. 19, 2017 -- First Hawaiian Bank, a subsidiary of First Hawaiian, Inc. (NASDAQ:FHB), today released the results of its 2017 Dodd-Frank Act Stress Test (“DFAST”) in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act and the implementing regulations of the Federal Deposit Insurance Corporation (the “FDIC”).
DFAST is a forward-looking exercise conducted by the FDIC and by banks supervised by the FDIC. The exercise helps assess whether institutions have sufficient capital to absorb losses and support operations during adverse economic and financial market conditions over a period of nine quarters. The projections and scenarios presented in the report are hypothetical and should not be regarded as forecasts of actual financial results or conditions. First Hawaiian Bank’s DFAST results can be found on First Hawaiian’s Investor Relations website at ir.fhb.com under Financial Reports.
About First Hawaiian
First Hawaiian, Inc. (NASDAQ:FHB) is a bank holding company headquartered in Honolulu, Hawaii. Its principal subsidiary, First Hawaiian Bank, founded in 1858 under the name Bishop & Company, is Hawaii’s oldest and largest financial institution with branch locations throughout Hawaii, Guam and Saipan. The company offers a comprehensive suite of banking services to consumer and commercial customers including deposit products, loans, wealth management, insurance, trust, retirement planning, credit card and merchant processing services. Customers may also access their accounts through ATMs, online and mobile banking channels. For more information about First Hawaiian, Inc., visit www.FHB.com
Investor Relations Contact:
Kevin Haseyama
(808) 525-6268
[email protected]
Media Contact:
Susan Kam
(808) 525-6254
[email protected]


Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



